Cambridge Healthtech Institute’s 9th Annual
Recovery and Purification – Parts 1 and 2
Optimising Downstream Efficacy and Yield
Part 1: March 10-11, 2026; Part 2: March 11-12, 2026
Rapid advances in chromatography, digitalisation, and emerging modalities are reshaping downstream processing. CHI’s 9th Annual Recovery and Purification 3-day conference stream will highlight innovations spanning DSP strategies for bispecifics, ADCs, and complex biologics, as well as new approaches for viral vectors, mRNA, and nanoparticle-based therapeutics. Speakers will share strategies for novel DSP methods, continuous purification, high-concentration formulations, and AI-driven monitoring and control. Additional sessions will explore sustainable DSP solutions, next-generation resins, and digital twins for process development, bringing together purification scientists, process engineers, and digital leaders to explore how these tools are advancing efficiency and product quality.
Coverage will include, but is not limited to:
- DSP Strategies for Multi-Specifics – bi-/multi-specifics, T-cell engagers, fusion proteins, PEGylated therapies, and nanobodies
- Antibody-Drug Conjugates and Bioconjugates – purification challenges, linker technologies, continuous processing, impurity control, and case studies
- Sustainability in DSP – solvent/buffer recycling, water reduction, and environmentally friendly technologies.
- Advances in Chromatography and Resins – novel ligands, affinity/membrane technologies, HCP/viral clearance, and 3D printing for purification
- High Concentration and Aggregation Challenges – formulation strategies for complex biologics and manufacturability impacts of protein engineering
- Digitalisation and Modelling in DSP – digital twins, PAT, mechanistic/predictive modelling, and AI-driven decision making
- ML/AI Approaches in Bioprocessing – optimising chromatography, DSP modelling, and conceptualising GEN AI bioprocesses
- Continuous Downstream Processing – strategies, hybrid/fully continuous workflows, process intensification, and real-time monitoring
- Purification of Advanced Therapeutics – viral vectors, plasmids, mRNA/LNPs, exosomes, antisense oligonucleotides, and RNA nanoparticles
- Microbial-Based Systems – process development for microbial platforms, including downstream processing innovations
The deadline for priority consideration is Friday 12 September
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: